Live RSS
Federal Grant · National Institutes of Health

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)

Last verified by NonDilute: 2026-04-29. Official notice and agency instructions control.

BiotechHealthcare Tech university-researchersmall-teamindividual-researcher
The pitch

If your early-stage biomedical or behavioral research is high-risk but potentially transformative, NIH will fund the conceptual proof without requiring a full clinical trial.

Award range
Unspecified
Closes
Jan 7, 2028 · 618d left
Open date
Dec 18, 2024
Difficulty
Medium
Source
Grants.gov
Agency
National Institutes of Health
Last verified
2026-04-29
Fit language
Possible fit only
Apply at grants.gov →

Report stale or inaccurate summary

What this is

This NIH grant targets exploratory and developmental research in biomedical, behavioral, and clinical sciences—particularly work in early conceptual stages that carries considerable risk but promises major field impact. It's designed for novel techniques, agents, methodologies, models, or applications rather than fully-developed research. Note that clinical trials are explicitly not allowed under this mechanism. The program spans 29 CFDA codes across diverse NIH institutes and centers, so fit depends heavily on your specific research topic and eligible institute.

Who can apply

Broad eligibility: universities (public and private), nonprofits with 501(c)(3) status, small businesses, state and local governments, tribal organizations, and for-profit entities. Solo founders must typically form a 501(c)(3) nonprofit or partner with an eligible institution; small-business structures are eligible. No geographic restrictions. Clinical trials are not allowed under this specific mechanism.

Eligible applicant types

Full description — from the agency

The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

Topics: nih exploratory grant · r21 developmental research · early-stage biomedical research · high-risk innovation · nih funding

Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.